SL STRATEGIES, LLC

Lobbying for ARGENTUM MEDICAL DBA BRAVIDA MEDICAL · leading manufacturer of antimicrobial solutions with an emphasis on hospital and surgery

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Illinois · House · Senate · $40,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Budget/Appropriations

Fiscal year 2026 appropriations for rad/nuc countermeasures within the HHS Strategic National Stockpile.

Health Issues

Policies impacting rad/nuc preparedness and response

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.